Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Compounded Bioidentical Hormone Therapy Market Growth 2022-2028

  • LP 4944712
  • 106 Pages
  • April 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Compounded Bioidentical Hormone Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Compounded Bioidentical Hormone Therapy market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Compounded Bioidentical Hormone Therapy market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Compounded Bioidentical Hormone Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Compounded Bioidentical Hormone Therapy market, reaching US$ million by the year 2028. As for the Europe Compounded Bioidentical Hormone Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Compounded Bioidentical Hormone Therapy players cover SottoPelle, BioTE Medical, Advantage Pharmaceuticals, and Full Life Wellness Center, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Compounded Bioidentical Hormone Therapy market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Oestrogen

Progesterone

Testosterone

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

SottoPelle

BioTE Medical

Advantage Pharmaceuticals

Full Life Wellness Center

Neuva Aesthetics

Defy Medical

Bio station

Noven Pharmaceuticals

Novartis AG

Pfizer

TherapeuticsMD

Bayer AG

Novo Nordisk

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Compounded Bioidentical Hormone Therapy Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Compounded Bioidentical Hormone Therapy by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Compounded Bioidentical Hormone Therapy by Country/Region, 2017, 2022 & 2028

2.2 Compounded Bioidentical Hormone Therapy Segment by Type

2.2.1 Oestrogen

2.2.2 Progesterone

2.2.3 Testosterone

2.3 Compounded Bioidentical Hormone Therapy Sales by Type

2.3.1 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2022)

2.3.2 Global Compounded Bioidentical Hormone Therapy Revenue and Market Share by Type (2017-2022)

2.3.3 Global Compounded Bioidentical Hormone Therapy Sale Price by Type (2017-2022)

2.4 Compounded Bioidentical Hormone Therapy Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.4.4 Others

2.5 Compounded Bioidentical Hormone Therapy Sales by Application

2.5.1 Global Compounded Bioidentical Hormone Therapy Sale Market Share by Application (2017-2022)

2.5.2 Global Compounded Bioidentical Hormone Therapy Revenue and Market Share by Application (2017-2022)

2.5.3 Global Compounded Bioidentical Hormone Therapy Sale Price by Application (2017-2022)

3 Global Compounded Bioidentical Hormone Therapy by Company

3.1 Global Compounded Bioidentical Hormone Therapy Breakdown Data by Company

3.1.1 Global Compounded Bioidentical Hormone Therapy Annual Sales by Company (2020-2022)

3.1.2 Global Compounded Bioidentical Hormone Therapy Sales Market Share by Company (2020-2022)

3.2 Global Compounded Bioidentical Hormone Therapy Annual Revenue by Company (2020-2022)

3.2.1 Global Compounded Bioidentical Hormone Therapy Revenue by Company (2020-2022)

3.2.2 Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Company (2020-2022)

3.3 Global Compounded Bioidentical Hormone Therapy Sale Price by Company

3.4 Key Manufacturers Compounded Bioidentical Hormone Therapy Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Compounded Bioidentical Hormone Therapy Product Location Distribution

3.4.2 Players Compounded Bioidentical Hormone Therapy Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Compounded Bioidentical Hormone Therapy by Geographic Region

4.1 World Historic Compounded Bioidentical Hormone Therapy Market Size by Geographic Region (2017-2022)

4.1.1 Global Compounded Bioidentical Hormone Therapy Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Compounded Bioidentical Hormone Therapy Annual Revenue by Geographic Region

4.2 World Historic Compounded Bioidentical Hormone Therapy Market Size by Country/Region (2017-2022)

4.2.1 Global Compounded Bioidentical Hormone Therapy Annual Sales by Country/Region (2017-2022)

4.2.2 Global Compounded Bioidentical Hormone Therapy Annual Revenue by Country/Region

4.3 Americas Compounded Bioidentical Hormone Therapy Sales Growth

4.4 APAC Compounded Bioidentical Hormone Therapy Sales Growth

4.5 Europe Compounded Bioidentical Hormone Therapy Sales Growth

4.6 Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Growth

5 Americas

5.1 Americas Compounded Bioidentical Hormone Therapy Sales by Country

5.1.1 Americas Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022)

5.1.2 Americas Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022)

5.2 Americas Compounded Bioidentical Hormone Therapy Sales by Type

5.3 Americas Compounded Bioidentical Hormone Therapy Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Compounded Bioidentical Hormone Therapy Sales by Region

6.1.1 APAC Compounded Bioidentical Hormone Therapy Sales by Region (2017-2022)

6.1.2 APAC Compounded Bioidentical Hormone Therapy Revenue by Region (2017-2022)

6.2 APAC Compounded Bioidentical Hormone Therapy Sales by Type

6.3 APAC Compounded Bioidentical Hormone Therapy Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Compounded Bioidentical Hormone Therapy by Country

7.1.1 Europe Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022)

7.1.2 Europe Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022)

7.2 Europe Compounded Bioidentical Hormone Therapy Sales by Type

7.3 Europe Compounded Bioidentical Hormone Therapy Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Compounded Bioidentical Hormone Therapy by Country

8.1.1 Middle East & Africa Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022)

8.1.2 Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022)

8.2 Middle East & Africa Compounded Bioidentical Hormone Therapy Sales by Type

8.3 Middle East & Africa Compounded Bioidentical Hormone Therapy Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Compounded Bioidentical Hormone Therapy

10.3 Manufacturing Process Analysis of Compounded Bioidentical Hormone Therapy

10.4 Industry Chain Structure of Compounded Bioidentical Hormone Therapy

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Compounded Bioidentical Hormone Therapy Distributors

11.3 Compounded Bioidentical Hormone Therapy Customer

12 World Forecast Review for Compounded Bioidentical Hormone Therapy by Geographic Region

12.1 Global Compounded Bioidentical Hormone Therapy Market Size Forecast by Region

12.1.1 Global Compounded Bioidentical Hormone Therapy Forecast by Region (2023-2028)

12.1.2 Global Compounded Bioidentical Hormone Therapy Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Compounded Bioidentical Hormone Therapy Forecast by Type

12.7 Global Compounded Bioidentical Hormone Therapy Forecast by Application

13 Key Players Analysis

13.1 SottoPelle

13.1.1 SottoPelle Company Information

13.1.2 SottoPelle Compounded Bioidentical Hormone Therapy Product Offered

13.1.3 SottoPelle Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 SottoPelle Main Business Overview

13.1.5 SottoPelle Latest Developments

13.2 BioTE Medical

13.2.1 BioTE Medical Company Information

13.2.2 BioTE Medical Compounded Bioidentical Hormone Therapy Product Offered

13.2.3 BioTE Medical Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BioTE Medical Main Business Overview

13.2.5 BioTE Medical Latest Developments

13.3 Advantage Pharmaceuticals

13.3.1 Advantage Pharmaceuticals Company Information

13.3.2 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offered

13.3.3 Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Advantage Pharmaceuticals Main Business Overview

13.3.5 Advantage Pharmaceuticals Latest Developments

13.4 Full Life Wellness Center

13.4.1 Full Life Wellness Center Company Information

13.4.2 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Offered

13.4.3 Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Full Life Wellness Center Main Business Overview

13.4.5 Full Life Wellness Center Latest Developments

13.5 Neuva Aesthetics

13.5.1 Neuva Aesthetics Company Information

13.5.2 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Offered

13.5.3 Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Neuva Aesthetics Main Business Overview

13.5.5 Neuva Aesthetics Latest Developments

13.6 Defy Medical

13.6.1 Defy Medical Company Information

13.6.2 Defy Medical Compounded Bioidentical Hormone Therapy Product Offered

13.6.3 Defy Medical Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Defy Medical Main Business Overview

13.6.5 Defy Medical Latest Developments

13.7 Bio station

13.7.1 Bio station Company Information

13.7.2 Bio station Compounded Bioidentical Hormone Therapy Product Offered

13.7.3 Bio station Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Bio station Main Business Overview

13.7.5 Bio station Latest Developments

13.8 Noven Pharmaceuticals

13.8.1 Noven Pharmaceuticals Company Information

13.8.2 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offered

13.8.3 Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Noven Pharmaceuticals Main Business Overview

13.8.5 Noven Pharmaceuticals Latest Developments

13.9 Novartis AG

13.9.1 Novartis AG Company Information

13.9.2 Novartis AG Compounded Bioidentical Hormone Therapy Product Offered

13.9.3 Novartis AG Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis AG Main Business Overview

13.9.5 Novartis AG Latest Developments

13.10 Pfizer

13.10.1 Pfizer Company Information

13.10.2 Pfizer Compounded Bioidentical Hormone Therapy Product Offered

13.10.3 Pfizer Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Pfizer Main Business Overview

13.10.5 Pfizer Latest Developments

13.11 TherapeuticsMD

13.11.1 TherapeuticsMD Company Information

13.11.2 TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Offered

13.11.3 TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 TherapeuticsMD Main Business Overview

13.11.5 TherapeuticsMD Latest Developments

13.12 Bayer AG

13.12.1 Bayer AG Company Information

13.12.2 Bayer AG Compounded Bioidentical Hormone Therapy Product Offered

13.12.3 Bayer AG Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Bayer AG Main Business Overview

13.12.5 Bayer AG Latest Developments

13.13 Novo Nordisk

13.13.1 Novo Nordisk Company Information

13.13.2 Novo Nordisk Compounded Bioidentical Hormone Therapy Product Offered

13.13.3 Novo Nordisk Compounded Bioidentical Hormone Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Novo Nordisk Main Business Overview

13.13.5 Novo Nordisk Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Compounded Bioidentical Hormone Therapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Compounded Bioidentical Hormone Therapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Oestrogen

Table 4. Major Players of Progesterone

Table 5. Major Players of Testosterone

Table 6. Global Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)

Table 7. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2022)

Table 8. Global Compounded Bioidentical Hormone Therapy Revenue by Type (2017-2022) & ($ million)

Table 9. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2022)

Table 10. Global Compounded Bioidentical Hormone Therapy Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)

Table 12. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2022)

Table 13. Global Compounded Bioidentical Hormone Therapy Revenue by Application (2017-2022)

Table 14. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Application (2017-2022)

Table 15. Global Compounded Bioidentical Hormone Therapy Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Compounded Bioidentical Hormone Therapy Sales by Company (2020-2022) & (K Units)

Table 17. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Company (2020-2022)

Table 18. Global Compounded Bioidentical Hormone Therapy Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Company (2020-2022)

Table 20. Global Compounded Bioidentical Hormone Therapy Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Compounded Bioidentical Hormone Therapy Producing Area Distribution and Sales Area

Table 22. Players Compounded Bioidentical Hormone Therapy Products Offered

Table 23. Compounded Bioidentical Hormone Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Compounded Bioidentical Hormone Therapy Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Compounded Bioidentical Hormone Therapy Sales Market Share Geographic Region (2017-2022)

Table 28. Global Compounded Bioidentical Hormone Therapy Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Compounded Bioidentical Hormone Therapy Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Country/Region (2017-2022)

Table 32. Global Compounded Bioidentical Hormone Therapy Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022) & (K Units)

Table 35. Americas Compounded Bioidentical Hormone Therapy Sales Market Share by Country (2017-2022)

Table 36. Americas Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Compounded Bioidentical Hormone Therapy Revenue Market Share by Country (2017-2022)

Table 38. Americas Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)

Table 39. Americas Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2022)

Table 40. Americas Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)

Table 41. Americas Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2022)

Table 42. APAC Compounded Bioidentical Hormone Therapy Sales by Region (2017-2022) & (K Units)

Table 43. APAC Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2017-2022)

Table 44. APAC Compounded Bioidentical Hormone Therapy Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Compounded Bioidentical Hormone Therapy Revenue Market Share by Region (2017-2022)

Table 46. APAC Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)

Table 47. APAC Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2022)

Table 48. APAC Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)

Table 49. APAC Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2022)

Table 50. Europe Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022) & (K Units)

Table 51. Europe Compounded Bioidentical Hormone Therapy Sales Market Share by Country (2017-2022)

Table 52. Europe Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Compounded Bioidentical Hormone Therapy Revenue Market Share by Country (2017-2022)

Table 54. Europe Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)

Table 55. Europe Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2022)

Table 56. Europe Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)

Table 57. Europe Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Compounded Bioidentical Hormone Therapy

Table 67. Key Market Challenges & Risks of Compounded Bioidentical Hormone Therapy

Table 68. Key Industry Trends of Compounded Bioidentical Hormone Therapy

Table 69. Compounded Bioidentical Hormone Therapy Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Compounded Bioidentical Hormone Therapy Distributors List

Table 72. Compounded Bioidentical Hormone Therapy Customer List

Table 73. Global Compounded Bioidentical Hormone Therapy Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Compounded Bioidentical Hormone Therapy Sales Market Forecast by Region

Table 75. Global Compounded Bioidentical Hormone Therapy Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Compounded Bioidentical Hormone Therapy Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Compounded Bioidentical Hormone Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Compounded Bioidentical Hormone Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Compounded Bioidentical Hormone Therapy Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Compounded Bioidentical Hormone Therapy Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Compounded Bioidentical Hormone Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Compounded Bioidentical Hormone Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Compounded Bioidentical Hormone Therapy Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Compounded Bioidentical Hormone Therapy Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Compounded Bioidentical Hormone Therapy Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Compounded Bioidentical Hormone Therapy Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Compounded Bioidentical Hormone Therapy Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Compounded Bioidentical Hormone Therapy Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Compounded Bioidentical Hormone Therapy Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Compounded Bioidentical Hormone Therapy Revenue Market Share Forecast by Application (2023-2028)

Table 93. SottoPelle Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 94. SottoPelle Compounded Bioidentical Hormone Therapy Product Offered

Table 95. SottoPelle Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. SottoPelle Main Business

Table 97. SottoPelle Latest Developments

Table 98. BioTE Medical Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 99. BioTE Medical Compounded Bioidentical Hormone Therapy Product Offered

Table 100. BioTE Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. BioTE Medical Main Business

Table 102. BioTE Medical Latest Developments

Table 103. Advantage Pharmaceuticals Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 104. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offered

Table 105. Advantage Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Advantage Pharmaceuticals Main Business

Table 107. Advantage Pharmaceuticals Latest Developments

Table 108. Full Life Wellness Center Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 109. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Product Offered

Table 110. Full Life Wellness Center Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Full Life Wellness Center Main Business

Table 112. Full Life Wellness Center Latest Developments

Table 113. Neuva Aesthetics Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 114. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Product Offered

Table 115. Neuva Aesthetics Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Neuva Aesthetics Main Business

Table 117. Neuva Aesthetics Latest Developments

Table 118. Defy Medical Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 119. Defy Medical Compounded Bioidentical Hormone Therapy Product Offered

Table 120. Defy Medical Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Defy Medical Main Business

Table 122. Defy Medical Latest Developments

Table 123. Bio station Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 124. Bio station Compounded Bioidentical Hormone Therapy Product Offered

Table 125. Bio station Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Bio station Main Business

Table 127. Bio station Latest Developments

Table 128. Noven Pharmaceuticals Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 129. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Product Offered

Table 130. Noven Pharmaceuticals Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Noven Pharmaceuticals Main Business

Table 132. Noven Pharmaceuticals Latest Developments

Table 133. Novartis AG Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 134. Novartis AG Compounded Bioidentical Hormone Therapy Product Offered

Table 135. Novartis AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Novartis AG Main Business

Table 137. Novartis AG Latest Developments

Table 138. Pfizer Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 139. Pfizer Compounded Bioidentical Hormone Therapy Product Offered

Table 140. Pfizer Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Pfizer Main Business

Table 142. Pfizer Latest Developments

Table 143. TherapeuticsMD Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 144. TherapeuticsMD Compounded Bioidentical Hormone Therapy Product Offered

Table 145. TherapeuticsMD Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. TherapeuticsMD Main Business

Table 147. TherapeuticsMD Latest Developments

Table 148. Bayer AG Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 149. Bayer AG Compounded Bioidentical Hormone Therapy Product Offered

Table 150. Bayer AG Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Bayer AG Main Business

Table 152. Bayer AG Latest Developments

Table 153. Novo Nordisk Basic Information, Compounded Bioidentical Hormone Therapy Manufacturing Base, Sales Area and Its Competitors

Table 154. Novo Nordisk Compounded Bioidentical Hormone Therapy Product Offered

Table 155. Novo Nordisk Compounded Bioidentical Hormone Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 156. Novo Nordisk Main Business

Table 157. Novo Nordisk Latest Developments

List of Figures

Figure 1. Picture of Compounded Bioidentical Hormone Therapy

Figure 2. Compounded Bioidentical Hormone Therapy Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Compounded Bioidentical Hormone Therapy Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Compounded Bioidentical Hormone Therapy Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Compounded Bioidentical Hormone Therapy Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Oestrogen

Figure 10. Product Picture of Progesterone

Figure 11. Product Picture of Testosterone

Figure 12. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Type in 2021

Figure 13. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Type (2017-2022)

Figure 14. Compounded Bioidentical Hormone Therapy Consumed in Hospital Pharmacies

Figure 15. Global Compounded Bioidentical Hormone Therapy Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 16. Compounded Bioidentical Hormone Therapy Consumed in Retail Pharmacies

Figure 17. Global Compounded Bioidentical Hormone Therapy Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 18. Compounded Bioidentical Hormone Therapy Consumed in Online Pharmacies

Figure 19. Global Compounded Bioidentical Hormone Therapy Market: Online Pharmacies (2017-2022) & (K Units)

Figure 20. Compounded Bioidentical Hormone Therapy Consumed in Others

Figure 21. Global Compounded Bioidentical Hormone Therapy Market: Others (2017-2022) & (K Units)

Figure 22. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Application (2017-2022)

Figure 23. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Application in 2021

Figure 24. Compounded Bioidentical Hormone Therapy Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Company in 2021

Figure 26. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Geographic Region in 2021

Figure 28. Global Compounded Bioidentical Hormone Therapy Sales Market Share by Region (2017-2022)

Figure 29. Global Compounded Bioidentical Hormone Therapy Revenue Market Share by Country/Region in 2021

Figure 30. Americas Compounded Bioidentical Hormone Therapy Sales 2017-2022 (K Units)

Figure 31. Americas Compounded Bioidentical Hormone Therapy Revenue 2017-2022 ($ Millions)

Figure 32. APAC Compounded Bioidentical Hormone Therapy Sales 2017-2022 (K Units)

Figure 33. APAC Compounded Bioidentical Hormone Therapy Revenue 2017-2022 ($ Millions)

Figure 34. Europe Compounded Bioidentical Hormone Therapy Sales 2017-2022 (K Units)

Figure 35. Europe Compounded Bioidentical Hormone Therapy Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue 2017-2022 ($ Millions)

Figure 38. Americas Compounded Bioidentical Hormone Therapy Sales Market Share by Country in 2021

Figure 39. Americas Compounded Bioidentical Hormone Therapy Revenue Market Share by Country in 2021

Figure 40. United States Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Compounded Bioidentical Hormone Therapy Sales Market Share by Region in 2021

Figure 45. APAC Compounded Bioidentical Hormone Therapy Revenue Market Share by Regions in 2021

Figure 46. China Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Compounded Bioidentical Hormone Therapy Sales Market Share by Country in 2021

Figure 53. Europe Compounded Bioidentical Hormone Therapy Revenue Market Share by Country in 2021

Figure 54. Germany Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Compounded Bioidentical Hormone Therapy Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Compounded Bioidentical Hormone Therapy Revenue Market Share by Country in 2021

Figure 61. Egypt Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Compounded Bioidentical Hormone Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Compounded Bioidentical Hormone Therapy in 2021

Figure 67. Manufacturing Process Analysis of Compounded Bioidentical Hormone Therapy

Figure 68. Industry Chain Structure of Compounded Bioidentical Hormone Therapy

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390